These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 26409125)

  • 21. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
    Gordi T; Hou E; Kasichayanula S; Berner B
    Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topiramate Extended Release: A Review in Epilepsy.
    Hoy SM
    CNS Drugs; 2016 Jun; 30(6):559-66. PubMed ID: 27224993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy.
    Sachdeo RC; Sachdeo SK; Walker SA; Kramer LD; Nayak RK; Doose DR
    Epilepsia; 1996 Aug; 37(8):774-80. PubMed ID: 8764818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects.
    Nunes T; Sicard E; Almeida L; Falcão A; Rocha JF; Brunet JS; Lefebvre M; Soares-da-Silva P
    Curr Med Res Opin; 2010 Jun; 26(6):1355-62. PubMed ID: 20377319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The practical impact of altered dosing on perampanel plasma concentrations: pharmacokinetic modeling from clinical studies.
    Gidal BE; Majid O; Ferry J; Hussein Z; Yang H; Zhu J; Fain R; Laurenza A
    Epilepsy Behav; 2014 Jun; 35():6-12. PubMed ID: 24785428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
    Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E
    Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steady-state pharmacokinetics and bioavailability of immediate-release and extended-release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodology.
    Polepally AR; Remmel RP; Brundage RC; Leppik IE; Rarick JO; Ramsay RE; Birnbaum AK
    J Clin Pharmacol; 2015 Oct; 55(10):1101-8. PubMed ID: 25903807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications.
    Bui K; Earley W; Nyberg S
    Curr Med Res Opin; 2013 Jul; 29(7):813-25. PubMed ID: 23574265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
    Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L
    Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulations.
    Leppik IE; Hovinga CA
    Epilepsia; 2013 Jan; 54(1):28-35. PubMed ID: 23190215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.
    Ahmad A; Garnett WR
    Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conversion from immediate-release to extended-release lamotrigine improves seizure control.
    Ramey P; Osborn M; Abou-Khalil B
    Epilepsy Res; 2014 Nov; 108(9):1637-41. PubMed ID: 25205163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of physiologically based pharmacokinetic model to evaluate the relative systemic exposure to quetiapine after administration of IR and XR formulations to adults, children and adolescents.
    Johnson TN; Zhou D; Bui KH
    Biopharm Drug Dispos; 2014 Sep; 35(6):341-52. PubMed ID: 24797229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of dosage, age, and co-medication on plasma topiramate concentrations in children and adults with severe epilepsy and preliminary observations on correlations with clinical response.
    Ferrari AR; Guerrini R; Gatti G; Alessandrì MG; Bonanni P; Perucca E
    Ther Drug Monit; 2003 Dec; 25(6):700-8. PubMed ID: 14639056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic interactions between topiramate and pioglitazone and metformin.
    Manitpisitkul P; Curtin CR; Shalayda K; Wang SS; Ford L; Heald D
    Epilepsy Res; 2014 Nov; 108(9):1519-32. PubMed ID: 25219351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary observations on topiramate in pediatric epilepsies.
    Glauser TA
    Epilepsia; 1997; 38 Suppl 1():S37-41. PubMed ID: 9092958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release.
    Figueroa C; Brecher M; Hamer-Maansson JE; Winter H
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):199-204. PubMed ID: 18948162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topiramate serum concentration-to-dose ratio: influence of age and concomitant antiepileptic drugs and monitoring implications.
    Adín J; Gómez MC; Blanco Y; Herranz JL; Armijo JA
    Ther Drug Monit; 2004 Jun; 26(3):251-7. PubMed ID: 15167623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.
    Sachdeo RC; Sachdeo SK; Levy RH; Streeter AJ; Bishop FE; Kunze KL; Mather GG; Roskos LK; Shen DD; Thummel KE; Trager WF; Curtin CR; Doose DR; Gisclon LG; Bialer M
    Epilepsia; 2002 Jul; 43(7):691-6. PubMed ID: 12102670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steady-state pharmacokinetics of nevirapine extended-release tablets in HIV-1-infected children and adolescents: an open-label, multiple-dose, cross-over study.
    Giaquinto C; Anabwani G; Feiterna-Sperling C; Nuttall J; Mompati K; Königs C; Mensa FJ; Sabo JP; Yong CL; MacGregor TR; Nguyen T; Quinson AM
    Pediatr Infect Dis J; 2014 Jul; 33(7):e173-9. PubMed ID: 24378938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.